HRR Reference Standards – 28‑Gene Panel for Homologous Recombination Repair Research！
Comprehensive reference material covering key HRR genes with diverse mutation types and allele frequencies.
Product Center
Product Introduce
OHomologous Recombination Repair (HRR) – 28‑Gene Reference Standard.Homologous recombination repair (HRR) is a critical pathway for DNA double‑strand break repair. Defects in HRR genes (e.g., BRCA1, BRCA2, ATM, PALB2) lead to genomic instability and are associated with breast, ovarian, prostate, pancreatic, and other cancers. Patients with HRR deficiency often benefit from PARP inhibitors and platinum‑based therapies.
CB-Gene’s HRR‑Related 28‑Gene Reference Standard (CBP90021/CBP90044) is a well‑characterized, cell‑line‑derived cocktail that mimics clinical samples. It contains all 28 HRR pathway genes (as defined by the ARIEL3 study), each carrying mutations with diverse types: missense, nonsense, insertions, deletions, splice variants, and copy number variations. The standard includes clinically annotated variants (Benign, Likely Benign, VUS, Likely Pathogenic, Pathogenic) and a wide range of allele frequencies (from 1–5% near LoD to 50–100% high frequency). It is validated by 1000x WES, 3500x targeted NGS panel, and ddPCR for select sites.
Product Advantages
Our HRR Reference Standards simulate precise variant allele frequencies (VAFs) mirroring real clinical samples.
Comprehensive Coverage
28 HRR pathway genes including BRCA1, BRCA2, ATM, ATR, BARD1, BLM, BRIP1, CDK12, CHEK1, CHEK2, FANCA, FANCC, FANCD2, FANCF, FANCI, FANCL, FANCM, MRE11A, NBN, PALB2, PPP2R2A, RAD50, RAD51B, RAD51C, RAD51D, RAD52, RAD54L, and RPA1.
Diverse mutation types
Missense, nonsense, frameshift insertions/deletions, splice site variants, and synonymous variants.
Full clinical annotation spectrum
Includes Benign, Likely Benign, Uncertain Significance, Likely Pathogenic, and Pathogenic variants.
Wide allele frequency range
From ~1–5% (near LoD), through 10–50% (medium), up to 100% (high/ homozygous).
Multi‑platform validation
Characterized by 1000x WES, 3500x targeted NGS panel, and ddPCR for key sites.
Patent‑protected technology
Developed based on Cobioer’s patent “Standard for DNA Homologous Recombination Repair Gene Detection and Its Preparation Method”.
Application
Assay Sensitivity, Linearity & LoD Determination
Research Kit Optimization & Performance Validation
Daily Quality Control & Translational Research Integration
Company Advantage
Expertise in reference standards – CB-Gene specializes in oncology molecular diagnostics with ISO‑certified production and patented technology.
Scientific Quality Management
With our ISO9001 certification, we adhere to a stringent quality management system, ensuring that all our products meet the highest standards of accuracy, stability, and consistency.
Experienced and Skilled Team
Backed by a talented team of experts, we leverage advanced technology and extensive experience to drive innovation in molecular diagnostics, ensuring we stay at the forefront of the industry.
Comprehensive annotation
Includes benign to pathogenic variants, helping you evaluate real‑world assay performance.
Comprehensive Product Range
We offer a complete set of reference materials, including SNP, Indel, CNV, Fusion, NIPT, and more, covering a wide array of diagnostic needs and offering customized services for a variety of applications.
Contact Us
We're here to assist you! Whether you have questions about our products, services, or need technical support, our team is ready to provide you with the information you need. Reach out to us today!
FAQs
Related Blogs
TF IHC Quality Controls for Targeted Therapy and Companion Diagnostics
Cobioer Gene provides combined positive and negative TF (Tissue Factor) IHC controls in two formats: FFPE tissue blocks and pre-cut FFPE control slides. The controls are validated by immunohistochemistry for routine quality control of TF IHC assays and companion diagnostic assay development. For Research Use Only.
Read More
PSMA IHC FFPE Controls: Paraffin Blocks vs. Pre-Cut Slides
The format of an IHC control can influence how easily a laboratory develops, validates, and monitors a PSMA staining workflow. While both paraffin blocks and pre-cut slides can be used as FFPE control materials, they support different laboratory needs.
Read More
PSMA IHC Positive and Negative 2-in-1 FFPE Control Standards
Reliable immunohistochemistry depends on more than selecting an antibody against the correct target. Laboratories also need appropriate control materials to evaluate whether the staining result is specific, interpretable, and reproducible.
Read More
ATP7B Reference Standards for Multi-Platform Wilson Disease Assay Validation
For laboratories developing and validating genetic tests for Wilson disease (WD), selecting appropriate ATP7B reference standards is an important part of establishing a controlled and reproducible assay. Wilson disease testing may use Sanger sequencing, quantitative real-time PCR (qPCR), droplet digital PCR (ddPCR), or targeted next-generation sequencing (NGS). Each workflow requires well-characterized genomic DNA reference materials to evaluate analytical performance, monitor run-to-run consistency, and support reliable ATP7B variant detection and genotyping. Suitable ATP7B reference standards should have clearly defined genotypes and variant identities, a relevant sample matrix, compatibility with the intended method, and characteristics aligned with the laboratory's validation plan. This article reviews the principal considerations when selecting ATP7B reference standards for multi-platform Wilson disease assay validation.
Read More
Get Touch With Us
Contact Info
Have questions or need assistance? We're here to help! Reach out to our team, and we'll provide the support you need.
